Facts on Vaccines
-
VACCINES: Barriers to Access
The major barriers to access are high vaccine prices, inadequate financing for immunisation, and weakness of national immunisation systemsLast updated 27 July 2011
-
VACCINES: Pharmaceutical Companies Production
The new and most expensive vaccines continue to be produced by a handful of multinational pharmaceutical companies who charge high pricesLast updated 27 July 2011
-
VACCINES: Un-Immunised Children
26 million children – roughly one in five born each year – remained un-immunised globallyLast updated 27 July 2011
-
Vaccine Sales
Total sales of vaccines are expected to grow from about US$20.5 billion in 2008 to $34 billion by 2012.Last updated 27 July 2011
-
Pharmaceutical Market
Vaccines make up 3% of the global pharmaceutical market.Last updated 27 July 2011
-
Unvaccinated Children
Each year, over 23 million children go unvaccinated, even though basic childhood immunisation is one of the few health interventions to which most of the world’s poor have access, free of charge and through the public sector.Last updated 27 July 2011
-
Barriers to Access
Major barriers to access include high vaccine prices, inadequate financing for certain immunisation initiatives and/or outbreak response, and weakness of national immunisation systemsLast updated 27 July 2011
-
Pneumococcal Conjugate
New vaccines like pneumococcal conjugate are produced by only a handful of multinational pharmaceutical companies who charge high prices.Last updated 27 July 2011
-
UNICEF & Vaccine Prices
Until January, 2011, the vaccine prices suppliers charged to UNICEF were unknown to the public.Last updated 27 July 2011
-
Cost of Immunisation Programs
With the introduction of new vaccines, the cost of immunisation programs in some countries is doubling, tripling, or even quadrupling.Last updated 27 July 2011
↑ To top
